![Jean-Michel Hotton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Michel Hotton
Keine laufenden Positionen mehr
Profil
Jean-Michel Hotton worked as a Director of Pharmaco Economic Affairs at Pfizer Inc. and as a Director at Fluxome Sciences A.
Ehemalige bekannte Positionen von Jean-Michel Hotton
Unternehmen | Position | Ende |
---|---|---|
Fluxome Sciences A/S
![]() Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | Direktor/Vorstandsmitglied | 08.08.2013 |
PFIZER, INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PFIZER, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Fluxome Sciences A/S
![]() Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | Health Technology |